Latest filing published 15 Sept 2026 for Mineralys Therapeutics, Inc., €74k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Karydas Daphne: trading record in brief
Karydas Daphne is a declared insider of Mineralys Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 2 filings; the first trade dates from 17 June 2026 and the latest from 15 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 15 September 2026, reports a transaction of €74k in Mineralys Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Karydas Daphne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,000 shares@ US$28.58Common StockSEC144:0001964306-26-000445
- 3,000 shares@ US$25.000.0030% mcap22.2% of flowCommon StockSEC144:0001964306-26-000292
2 of 2 declarations
